|
|
|
|
|
|
This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
The Disease-Host Dual-System FrameworkA Systems Architecture for Cancer and Chronic DiseaseBy Richard Z. Cheng, MD, PhD
AbstractPatients with similar chronic diseases frequently experience markedly different clinical outcomes despite comparable diagnoses and treatments. We propose the Disease-Host Dual-System Framework, a conceptual architecture in which every chronic disease is understood as the interaction between an adaptive Disease System and an adaptive Host System. From this framework follow four logical consequences: clinical outcome is determined by the balance between Disease Pressure and Host Capacity; effective therapy modifies both; Host Capacity can be systematically strengthened; and the same architecture applies across chronic diseases. Together these concepts establish the theoretical foundation of Integrative Orthomolecular Systems Medicine I OM . IntroductionPatients with similar diseases often experience different outcomes despite similar diagnoses and treatments. Disease biology alone cannot fully explain these differences. While remarkable progress has been made in elucidating diseasespecific mechanisms, contemporary medicine increasingly recognizes the importance of systems-level interactions between pathology and the host [1-3]. We propose that the missing variable is the relationship between disease and the host in which it develops. The five figures that follow present a single conceptual framework and its logical consequences.
Figure 1. The Disease-Host Dual-System FrameworkEvery chronic disease consists of two adaptive biological systems: the Disease System and the Host System. The Disease System encompasses the biological processes that initiate, sustain, and adapt during disease progression. The Host System comprises the physiological processes that maintain homeostasis, adaptation, repair, and survival. Neither system functions independently. Disease continuously modifies host physiology, while the host continuously responds through metabolic adaptation, immune regulation, and tissue repair. Clinical outcome therefore emerges from the interaction between these adaptive systems rather than from either system alone. This framework shifts the central question of medicine from How do we eliminate disease? to How do we optimize the interaction between disease and host? This perspective is consistent with systems biology, which emphasizes dynamic interactions among biological networks rather than isolated pathways [2].
Figure 2. Disease Pressure and Host CapacityThe interaction between the Disease System and the Host System is expressed as the balance between Disease Pressure and Host Capacity. Disease Pressure represents the aggregate biological burden generated by disease. Host Capacity represents the integrated physiological reserve available to maintain function, adapt to stress, and recover from injury. Clinical deterioration occurs when Disease Pressure exceeds Host Capacity. Recovery becomes possible when Host Capacity equals or exceeds Disease Pressure. The concept of Host Capacity is related to established physiological concepts including homeostasis, allostasis, and physiological reserve [4, 5] . Both variables are dynamic and continuously influenced by disease progression, aging, lifestyle, environmental exposures, and therapeutic intervention. Clinical outcome is therefore determined by their relationship rather than by disease burden alone.
Figure 3. Therapeutic Window Engineering in I OM Systems MedicineIf clinical outcome depends on the balance between Disease Pressure and Host Capacity, therapy should modify both. Conventional medicine primarily reduces Disease Pressure through disease-specific interventions. Cancer therapy provides a clear example in which disease-directed treatment may improve disease control while simultaneously reducing physiological reserve, thereby limiting the therapeutic window [6]. The Disease-Host Dual-System Framework expands this objective by simultaneously preserving or increasing Host Capacity. Disease-directed therapy and host optimization therefore become complementary rather than competing strategies. Therapeutic success is achieved not only by suppressing disease but also by expanding the therapeutic window through preservation of physiological reserve.
Figure 4. Universal Host OptimizationHost Capacity is not fixed. It can be systematically strengthened through hierarchical physiological optimization. Lifestyle, nutrition, metabolic health, endocrine regulation, mitochondrial function, immune competence, environmental health, and restorative therapies collectively determine the adaptive capacity of the host [7-9] . Although these interventions may not directly target disease-specific mechanisms, they strengthen the physiological foundation upon which all disease-directed therapies depend. Universal Host Optimization therefore represents a common therapeutic strategy across chronic diseases. ConclusionThe Disease-Host Dual-System Framework begins with a single proposition: every chronic disease represents the interaction between an adaptive Disease System and an adaptive Host System. From this proposition follow four logical consequences: clinical outcome is determined by the balance between Disease Pressure and Host Capacity; therapy should modify both; Host Capacity can be systematically strengthened; and the same systems architecture applies across chronic diseases. Together these concepts establish the conceptual foundation of Integrative Orthomolecular Systems Medicine I OM . We hope this framework serves as a conceptual foundation for future hypothesis generation, experimental validation, and clinical implementation. DeclarationsAuthor ContributionsRichard Z. Cheng, MD, PhD R.Z.C. conceived the Disease-Host Dual-System Framework, developed the conceptual model, designed the figures, conducted the literature review, and wrote, reviewed, and approved the final manuscript. FundingThis research received no external funding. Institutional Review Board StatementNot applicable. Informed Consent StatementNot applicable. Data Availability StatementNo new data were generated or analyzed in this conceptual study. Data sharing is not applicable. Conflicts of InterestThe author declares no conflicts of interest. AcknowledgmentsThe author gratefully acknowledges the many researchers whose pioneering work in systems biology, systems medicine, homeostasis, cancer biology, orthomolecular medicine, and integrative medicine has contributed to the scientific foundation upon which this conceptual framework was developed. References1. Engel, G.L. The Need for a New Medical Model: A Challenge forBiomedicine. Science 1977, 196, 4286 , 129 136. DOI 10.1126/science.847460. 2. Kitano, H. Systems Biology: A Brief Overview. Science 2002, 295, 5560 , 1662 1664. DOI 10.1126/science.1069492. 3. Hood, L.; Friend, S.H. Predictive, Personalized, Preventive, Participatory P4 Cancer Medicine. Nat Rev Clin Oncol 2011, 8, 3 , 184 187. DOI 10.1038/nrclinonc.2010.227. 4. Sterling, P. Allostasis: A Model of Predictive Regulation. Physiol Behav 2012, 106, 1 , 5 15. DOI 10.1016/j.physbeh.2011.06.004. 5. Cannon, Walter B. The Wisdom of the Body; W. W. Norton & Company, New York, 1963. 6. Hanahan, D.; Weinberg, R.A. The Hallmarks of Cancer. Cell 2000, 100, 1 , 57 70. DOI 10.1016/s0092-8674(00)81683-9. 7. Cheng, R.Z. Beyond Cholesterol: A Comprehensive Integrative and Systems Medicine Reassessment of Lipid and Lipoprotein Biomarkers in ASCVD. 2026. DOI 10.20944/preprints202607.0008.v1; Available online: https://www.preprints.org/manuscript/202607.0008. 8. Cheng, R.Z.; Levy, T.E.; Hunninghake, R. The Insulin-Cortisol-Vitamin C Axis: A Missing Regulatory Framework in Metabolic and Hormonal Homeostasis A Narrative Review. 2025. DOI 10.20944/preprints202512.0217.v1; Available online: https://www.preprints.org/manuscript/202512.0217. 9. Cheng, R.Z. Systemic Leaky Barrier Syndrome SLBS A Systems-Level Framework for Chronic Disease. 2026. DOI 10.20944/preprints202602.0069.v2; Available online: https://www.preprints.org/manuscript/202602.0069. Reader Q&A and Orthomolecular Certificate Training CoursesJoin OMNS Global for multilingual OMNS content, reader Q&A and discussion, searchable resources, AI-assisted learning through I-OM.ai, news and events, orthomolecular certificate training courses, and international collaboration. OMNS Global is the OMNS for the AI age, an international, multilingual community and education platform of the Orthomolecular Medicine News Service (OMNS). Orthomolecular.org remains the official archive of OMNS publications. Content is provided for educational purposes only and does not constitute medical advice. Follow OMNS Global Reader Discussion and QuestionsOMNS welcomes comments, questions, ideas, experiences, and respectful dialogue from readers, patients, healthcare professionals, researchers, and students worldwide. We encourage participation on OMNS Interactive, where the exchange of knowledge and perspectives helps advance understanding and foster meaningful discussion. Join the conversation:
About OMNS InteractiveOMNS Interactive is the discussion and commentary platform of the Orthomolecular Medicine News Service (OMNS). The original OMNS website remains the official archive of OMNS publications. Subscribe to OMNS Interactive for future articles, commentary, and discussions:
Content is provided for educational purposes only and does not constitute medical advice. Follow OMNS Interactive
Orthomolecular MedicineOrthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org Find a DoctorTo locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource. Editorial Review Board:
Jennifer L. Aliano, M.S., L.Ac., C.C.N. (USA)
Comments and media contact: editor@orthomolecular.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication. To Subscribe at no charge: https://www.orthomolecular.org/subscribe.html To Unsubscribe from this list: https://www.orthomolecular.org/unsubscribe.html |
This website is managed by Riordan Clinic
A Non-profit 501(c)(3) Medical, Research and Educational Organization
3100 North Hillside Avenue, Wichita, KS 67219 USA
Phone: 316-682-3100; Fax: 316-682-5054
© (Riordan Clinic) 2004 - 2024c
Information on Orthomolecular.org is provided for educational purposes only. It is not intended as medical advice.
Consult your orthomolecular health care professional for individual guidance on specific health problems.
